As part of the goal of creating a biomarker-based diagnostic test for OC, this pilot study examined nine main gene expression biomarkers of the Notch and Wnt pathways and the OC susceptibility gene ARID1A for expression changes in patients with gynecologic tumors. Here, ARID1A is linked to female reproductive system neoplasm.